Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients.

Zhang Q, Jin XS, Yang ZY, Wei M, Liu BY, Gu QL.

Neoplasma. 2013;60(4):439-45. doi: 10.4149/neo_2013_057.

PMID:
23581417
2.

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.

Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z.

Ann Surg Oncol. 2011 Dec;18(13):3858-67. doi: 10.1245/s10434-011-1668-5. Epub 2011 Mar 26.

PMID:
21442347
3.

Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery.

Zhang Q, Jin XS, Yang ZY, Wei M, Zhu XC, Wang P, Liu BY, Gu QL.

Oncol Lett. 2013 Mar;5(3):896-902. Epub 2012 Dec 27.

4.

Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z.

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.

5.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

6.

Clinical significance of Zinc finger E-box Binding homeobox 1 (ZEB1) in human gastric cancer.

Okugawa Y, Toiyama Y, Tanaka K, Matsusita K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K, Kusunoki M.

J Surg Oncol. 2012 Sep 1;106(3):280-5. doi: 10.1002/jso.22142. Epub 2011 Nov 17.

PMID:
22095522
7.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.

PMID:
23334926
8.

Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.

Li W, Yu CP, Xia JT, Zhang L, Weng GX, Zheng HQ, Kong QL, Hu LJ, Zeng MS, Zeng YX, Li M, Li J, Song LB.

Clin Cancer Res. 2009 Feb 15;15(4):1393-9. doi: 10.1158/1078-0432.CCR-08-1158.

9.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
10.

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Wang DD, Chen YB, Pan K, Wang W, Chen SP, Chen JG, Zhao JJ, Lv L, Pan QZ, Li YQ, Wang QJ, Huang LX, Ke ML, He J, Xia JC.

PLoS One. 2012;7(7):e40364. doi: 10.1371/journal.pone.0040364. Epub 2012 Jul 13.

11.

Decreased expression of T-cadherin is associated with gastric cancer prognosis.

Tang Y, Dai Y, Huo J.

Hepatogastroenterology. 2012 Jun;59(116):1294-8. doi: 10.5754/hge12016.

PMID:
22414547
12.

Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival.

Zhao ZQ, Yang S, Lu HS.

Mol Med Rep. 2012 Feb;5(2):415-9. doi: 10.3892/mmr.2011.649. Epub 2011 Oct 31.

PMID:
22051879
13.

Dickkopf-1 expression is a novel prognostic marker for gastric cancer.

Gao C, Xie R, Ren C, Yang X.

J Biomed Biotechnol. 2012;2012:804592. doi: 10.1155/2012/804592. Epub 2012 Mar 4.

14.

Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer.

Chen Y, Pan K, Li S, Xia J, Wang W, Chen J, Zhao J, Lü L, Wang D, Pan Q, Wang Q, Li Y, He J, Li Q.

J Surg Oncol. 2012 Sep 1;106(3):286-93. doi: 10.1002/jso.22150. Epub 2011 Nov 17.

PMID:
22095633
15.

[Expression of S100A6 in primary and metastatic human gastric cancer].

Huang HL, Wu BY, Zhu XD, You WD, Wang WH, Wang MW.

Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):506-10. Chinese.

PMID:
19062716
16.

Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.

Zheng HC, Xu XY, Xia P, Yu M, Takahashi H, Takano Y.

Hum Pathol. 2010 Sep;41(9):1255-64. doi: 10.1016/j.humpath.2010.02.003. Epub 2010 May 5.

PMID:
20447678
17.

Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Luo D, Huang H, Lu ML, Zhao GF, Chang J, Zheng MY, Wang Y.

Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x. Epub 2011 Nov 23.

PMID:
22109561
18.

The overexpression of AP-4 as a prognostic indicator for gastric carcinoma.

Xinghua L, Bo Z, Yan G, Lei W, Changyao W, Qi L, Lin Y, Kaixiong T, Guobin W, Jianying C.

Med Oncol. 2012 Jun;29(2):871-7. doi: 10.1007/s12032-011-9845-8. Epub 2011 Feb 20.

PMID:
21336989
19.

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H.

Cancer Sci. 2006 Jun;97(6):484-91.

20.

Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.

Wen YG, Wang Q, Zhou CZ, Yan DW, Qiu GQ, Yang C, Tang HM, Peng ZH.

J Surg Oncol. 2011 Oct;104(5):516-24. doi: 10.1002/jso.21981. Epub 2011 May 25.

PMID:
21618246
Items per page

Supplemental Content

Write to the Help Desk